Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Owens & Minor Inc (OMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012251
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Owens & Minor Inc (Owens & Minor) is a healthcare services company, which provides supply chain services to healthcare providers and manufacturers of healthcare products. It provides logistics services for disposable medical supplies, devices and implants. Owens & Minor offers medical and surgical products related to admission, anesthesia, diagnostics and equipment, maternity and nursery, O.R. products, patient care, respiratory, and urology. It also offers distribution services and supply-chain management services to healthcare providers and suppliers of medical and surgical products. The company offers its products and services to independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare products’ manufacturers, and the federal government. It has operations in North America and Europe. Owens & Minor is headquartered in Richmond, Virginia, the US.

Owens & Minor Inc (OMI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Owens & Minor Inc, Medical Devices Deals, 2011 to YTD 2017 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Acquisition 15
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc – Key Competitors 18
Owens & Minor Inc – Key Employees 19
Owens & Minor Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 23
Financial Announcements 23
Nov 01, 2017: Owens & Minor Reports 3rd Quarter 2017 Financial Results 23
Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 25
May 02, 2017: Owens & Minor Reports 1st Quarter 2017 Financial Results 27
Mar 16, 2017: Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018 at Annual Investor Meeting 28
Feb 14, 2017: Owens & Minor Reports 4th Quarter & Full-Year 2016 Financial Results 29
Nov 01, 2016: Owens & Minor Releases 3rd Quarter 2016 Financial Results 31
Aug 02, 2016: Owens & Minor Reports 2nd Quarter 2016 Financial Results 33
May 03, 2016: Owens & Minor Reports 1st Quarter 2016 Financial Results 35
Feb 08, 2016: Owens & Minor Reports 4th Quarter & Full-Year 2015 Financial Results 37
Corporate Communications 39
Mar 13, 2017: Owens & Minor Welcomes New EVP of Global Manufacturer Services 39
Feb 10, 2017: Owens & Minor Announces That Healthcare Executive Barbara B. Hill Has Been Elected to Its Board of Directors 40
Feb 10, 2017: Craig R. Smith, Chairman of the Owens & Minor Board of Directors, Announces His Retirement 41
Other Significant Developments 42
Oct 23, 2017: Healthier Communities 20/20: A Clear Vision for Our Future; Owens & Minor will Explore this Theme at its 12th Annual Healthcare Supplier Diversity Symposium 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Owens & Minor Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Owens & Minor Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Owens & Minor Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Owens & Minor Inc, Medical Devices Deals, 2011 to YTD 2017 9
Owens & Minor Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Owens & Minor Completes Public Offering of 3.875% Notes Due 2021 for USD275 Million 11
Owens & Minor Completes Public Offering of 4.375% Notes Due 2024 for USD275 Million 13
Owens & Minor to Acquire Byram Healthcare 15
Owens & Minor Completes Acquisition Of Movianto From Celesio For US$158 Million 17
Owens & Minor Inc, Key Competitors 18
Owens & Minor Inc, Key Employees 19
Owens & Minor Inc, Other Locations 20
Owens & Minor Inc, Subsidiaries 21

★海外企業調査レポート[Owens & Minor Inc (OMI)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laboratoires Pierre Fabre SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation develops products and solutions ranging from health to beauty. Its product portfolio comprises wide range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs …
  • Crescent Point Energy Corp. (CPG)-石油・ガス分野:企業M&A・提携分析
    Summary Crescent Point Energy Corp. (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and nat …
  • Pilot Energy Ltd (PGY):電力:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • Halliburton Company:企業の戦略・SWOT・財務情報
    Halliburton Company - Strategy, SWOT and Corporate Finance Report Summary Halliburton Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cocoon Holdings Ltd (428):企業の財務・戦略的SWOT分析
    Cocoon Holdings Ltd (428) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Franklin Covey Co. (FC):企業の財務・戦略的SWOT分析
    Franklin Covey Co. (FC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pharming Group NV (PHARM):企業の財務・戦略的SWOT分析
    Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TPI Composites Inc (TPIC):電力:M&Aディール及び事業提携情報
    Summary TPI Composites Inc (TPI) is a provider of wind energy products and composite materials. The company designs and manufactures composite wind blades and provides single source solutions to the global wind turbine manufacturers. The company also provides precision molding and assembly systems u …
  • The Bank of Yokohama, Ltd.:企業の戦略・SWOT・財務情報
    The Bank of Yokohama, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Bank of Yokohama, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Telekom Malaysia Berhad:企業の戦略・SWOT・財務情報
    Telekom Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Telekom Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Frito-Lay North America, Inc.:企業の戦略・SWOT・財務情報
    Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Corline Biomedical AB (CLBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Corline Biomedical AB (Corline Biomedical), formerly Corline Systems AB is a manufacturer of heparin based solutions. The company offers heparin based solutions to improve kidney transplantation, and applications in the field of regenerative medicine. Its regentrative medicines include cytop …
  • The Empire District Electric Co:企業の戦略的SWOT分析
    The Empire District Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Albéa Beauty Holdings S.A.:戦略・SWOT・企業財務分析
    Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report Summary Albéa Beauty Holdings S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Hydra Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Hydra Biosciences Inc (Hydra) is a biopharmaceutical company that develops novel drugs. The company’s pipeline candidate HX-100 is developed to treat diabetic neuropathy and allergic asthma. It offers other drugs for the therapeutic areas including inflammation, pain, renal, anxiety and pulm …
  • Essar Power Limited:電力:M&Aディール及び事業提携情報
    Summary Essar Power Limited (Essar Power) a subsidiary of Essar Energy Limited, is an electric utility. It produces electricity and thermal energy. The company generates power from naphtha, high-speed diesel, coal, natural gasoline liquid, and natural gas sources. Essar Power owns and operates co-ge …
  • Kootenai Electric Cooperative, Inc.:発電所・企業SWOT分析
    Kootenai Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • CTI Engineering Co Ltd:企業の戦略・SWOT・財務情報
    CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆